COVID-19-Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study.
Black or African American
/ statistics & numerical data
Age Distribution
Aged
Aged, 80 and over
COVID-19
/ ethnology
Female
Health Status Disparities
Hispanic or Latino
/ statistics & numerical data
Hospitalization
/ statistics & numerical data
Hospitals, Veterans
Humans
Male
Population Surveillance
/ methods
Treatment Outcome
United States
/ epidemiology
Veterans
/ statistics & numerical data
White People
/ statistics & numerical data
COVID-19
at-risk
fatality
hospitalization
mortality
outcome
prevention
veteran
Journal
JMIR public health and surveillance
ISSN: 2369-2960
Titre abrégé: JMIR Public Health Surveill
Pays: Canada
ID NLM: 101669345
Informations de publication
Date de publication:
22 01 2021
22 01 2021
Historique:
received:
22
09
2020
accepted:
14
12
2020
revised:
05
12
2020
pubmed:
19
12
2020
medline:
29
1
2021
entrez:
18
12
2020
Statut:
epublish
Résumé
COVID-19 has disproportionately affected older adults and certain racial and ethnic groups in the United States. Data quantifying the disease burden, as well as describing clinical outcomes during hospitalization among these groups, are needed. We aimed to describe interim COVID-19 hospitalization rates and severe clinical outcomes by age group and race and ethnicity among US veterans by using a multisite surveillance network. We implemented a multisite COVID-19 surveillance platform in 5 Veterans Affairs Medical Centers located in Atlanta, Bronx, Houston, Palo Alto, and Los Angeles, collectively serving more than 396,000 patients annually. From February 27 to July 17, 2020, we actively identified inpatient cases with COVID-19 by screening admitted patients and reviewing their laboratory test results. We then manually abstracted the patients' medical charts for demographics, underlying medical conditions, and clinical outcomes. Furthermore, we calculated hospitalization incidence and incidence rate ratios, as well as relative risk for invasive mechanical ventilation, intensive care unit admission, and case fatality rate after adjusting for age, race and ethnicity, and underlying medical conditions. We identified 621 laboratory-confirmed, hospitalized COVID-19 cases. The median age of the patients was 70 years, with 65.7% (408/621) aged ≥65 years and 94% (584/621) male. Most COVID-19 diagnoses were among non-Hispanic Black (325/621, 52.3%) veterans, followed by non-Hispanic White (153/621, 24.6%) and Hispanic or Latino (112/621, 18%) veterans. Hospitalization rates were the highest among veterans who were ≥85 years old, Hispanic or Latino, and non-Hispanic Black (430, 317, and 298 per 100,000, respectively). Veterans aged ≥85 years had a 14-fold increased rate of hospitalization compared with those aged 18-29 years (95% CI: 5.7-34.6), whereas Hispanic or Latino and Black veterans had a 4.6- and 4.2-fold increased rate of hospitalization, respectively, compared with non-Hispanic White veterans (95% CI: 3.6-5.9). Overall, 11.6% (72/621) of the patients required invasive mechanical ventilation, 26.6% (165/621) were admitted to the intensive care unit, and 16.9% (105/621) died in the hospital. The adjusted relative risk for invasive mechanical ventilation and admission to the intensive care unit did not differ by age group or race and ethnicity, but veterans aged ≥65 years had a 4.5-fold increased risk of death while hospitalized with COVID-19 compared with those aged <65 years (95% CI: 2.4-8.6). COVID-19 surveillance at the 5 Veterans Affairs Medical Centers across the United States demonstrated higher hospitalization rates and severe outcomes among older veterans, as well as higher hospitalization rates among Hispanic or Latino and non-Hispanic Black veterans than among non-Hispanic White veterans. These findings highlight the need for targeted prevention and timely treatment for veterans, with special attention to older aged, Hispanic or Latino, and non-Hispanic Black veterans.
Sections du résumé
BACKGROUND
COVID-19 has disproportionately affected older adults and certain racial and ethnic groups in the United States. Data quantifying the disease burden, as well as describing clinical outcomes during hospitalization among these groups, are needed.
OBJECTIVE
We aimed to describe interim COVID-19 hospitalization rates and severe clinical outcomes by age group and race and ethnicity among US veterans by using a multisite surveillance network.
METHODS
We implemented a multisite COVID-19 surveillance platform in 5 Veterans Affairs Medical Centers located in Atlanta, Bronx, Houston, Palo Alto, and Los Angeles, collectively serving more than 396,000 patients annually. From February 27 to July 17, 2020, we actively identified inpatient cases with COVID-19 by screening admitted patients and reviewing their laboratory test results. We then manually abstracted the patients' medical charts for demographics, underlying medical conditions, and clinical outcomes. Furthermore, we calculated hospitalization incidence and incidence rate ratios, as well as relative risk for invasive mechanical ventilation, intensive care unit admission, and case fatality rate after adjusting for age, race and ethnicity, and underlying medical conditions.
RESULTS
We identified 621 laboratory-confirmed, hospitalized COVID-19 cases. The median age of the patients was 70 years, with 65.7% (408/621) aged ≥65 years and 94% (584/621) male. Most COVID-19 diagnoses were among non-Hispanic Black (325/621, 52.3%) veterans, followed by non-Hispanic White (153/621, 24.6%) and Hispanic or Latino (112/621, 18%) veterans. Hospitalization rates were the highest among veterans who were ≥85 years old, Hispanic or Latino, and non-Hispanic Black (430, 317, and 298 per 100,000, respectively). Veterans aged ≥85 years had a 14-fold increased rate of hospitalization compared with those aged 18-29 years (95% CI: 5.7-34.6), whereas Hispanic or Latino and Black veterans had a 4.6- and 4.2-fold increased rate of hospitalization, respectively, compared with non-Hispanic White veterans (95% CI: 3.6-5.9). Overall, 11.6% (72/621) of the patients required invasive mechanical ventilation, 26.6% (165/621) were admitted to the intensive care unit, and 16.9% (105/621) died in the hospital. The adjusted relative risk for invasive mechanical ventilation and admission to the intensive care unit did not differ by age group or race and ethnicity, but veterans aged ≥65 years had a 4.5-fold increased risk of death while hospitalized with COVID-19 compared with those aged <65 years (95% CI: 2.4-8.6).
CONCLUSIONS
COVID-19 surveillance at the 5 Veterans Affairs Medical Centers across the United States demonstrated higher hospitalization rates and severe outcomes among older veterans, as well as higher hospitalization rates among Hispanic or Latino and non-Hispanic Black veterans than among non-Hispanic White veterans. These findings highlight the need for targeted prevention and timely treatment for veterans, with special attention to older aged, Hispanic or Latino, and non-Hispanic Black veterans.
Identifiants
pubmed: 33338028
pii: v7i1e24502
doi: 10.2196/24502
pmc: PMC7836907
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e24502Informations de copyright
©Cristina V Cardemil, Rebecca Dahl, Mila M Prill, Jordan Cates, Sheldon Brown, Adrienne Perea, Vincent Marconi, LaSara Bell, Maria C Rodriguez-Barradas, Gilberto Rivera-Dominguez, David Beenhouwer, Aleksandra Poteshkina, Mark Holodniy, Cynthia Lucero-Obusan, Neha Balachandran, Aron J Hall, Lindsay Kim, Gayle Langley. Originally published in JMIR Public Health and Surveillance (http://publichealth.jmir.org), 22.01.2021.
Références
MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1528-1534
pubmed: 33090987
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Brain Behav Immun. 2020 Aug;88:44-49
pubmed: 32497776
JAMA Netw Open. 2020 Sep 1;3(9):e2022310
pubmed: 32965502
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Rand Health Q. 2016 May 9;5(4):13
pubmed: 28083423
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
PLoS Med. 2020 Sep 22;17(9):e1003379
pubmed: 32960880
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464
pubmed: 32298251
Clin Infect Dis. 2020 Jun 25;:
pubmed: 32584956
Clin Infect Dis. 2020 Jan 1;70(1):40-48
pubmed: 30901024
Clin Infect Dis. 2020 Jul 16;:
pubmed: 32674114
MMWR Morb Mortal Wkly Rep. 2020 May 08;69(18):545-550
pubmed: 32379729
BMJ. 2020 Apr 20;369:m1548
pubmed: 32312785